Arcturus Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $38,815 | $45,976 | $32,598 | $28,212 |
Gross Profit | 41,673 | 45,076 | 38,012 | 27,397 |
EBITDA | -9,825 | -16,466 | -25,545 | -7,492 |
EBIT | -10,737 | -17,366 | -26,449 | -8,307 |
Net Income | -6,903 | -17,216 | -26,817 | -8,573 |
Net Change In Cash | 38,815 | 45,976 | 32,598 | 28,212 |
Free Cash Flow | -23,493 | -30,172 | -5,797 | -1,381 |
Cash | 237,178 | 315,329 | 288,396 | 347,005 |
Basic Shares | 27,062 | 26,967 | 26,879 | 26,628 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $157,748 | $205,755 | $12,359 | $9,539 |
Gross Profit | 154,791 | 62,704 | -159,501 | -46,407 |
EBITDA | -24,166 | 13,704 | -201,659 | -70,642 |
EBIT | -27,123 | 12,177 | -202,852 | -71,524 |
Net Income | -29,725 | 9,349 | -206,863 | -71,364 |
Net Change In Cash | 157,748 | 205,755 | 12,359 | 9,539 |
Cost of Revenue | -90,433 | 391,542 | ||
Free Cash Flow | -21,000 | 24,267 | -138,449 | -44,603 |
Cash | 292,005 | 391,883 | 370,492 | 462,895 |
Basic Shares | 26,628 | 27,093 | 26,317 | 20,305 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.26 |
2024-06-30 | -$0.64 |
2024-03-31 | -$1 |
2023-12-31 | -$0.32 |
